Clinical and experimental studies reveal that low ADAMTS13 plasma levels are associated with an increased risk of myocardial infarction, stroke, or arterial thrombosis in subarachnoid hemorrhage [40,48,49,50,51,52,53]. The gene discussed is ADAMTS13; the disease is myocardial infarction.